Creating a hospital register for patients with heart failure and preserved ejection fraction
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
This study is trying to create a hospital registry for patients with heart failure and preserved ejection fraction to better understand their health and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 160 (estimated) |
| Ages | 40 Years to 80 Years |
| Sex | All |
| Sponsor | National Medical Research Center for Therapy and Preventive Medicine Government |
| Drugs / interventions | Chemotherapy |
| Locations | 2 sites (Moscow and 1 other locations) |
| Trial ID | NCT06114498 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a comprehensive hospital register for patients experiencing acute decompensated heart failure with preserved ejection fraction (HFpEF). It will assess various factors including gender characteristics, clinical history, body composition, and markers of inflammation to understand their impact on patient outcomes. The study will involve collecting data from hospitalized patients, analyzing their comorbid conditions, and evaluating treatment approaches both before and during hospitalization. The goal is to identify predictors of adverse outcomes and optimize treatment strategies for this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are patients hospitalized with acute decompensated heart failure showing symptoms such as shortness of breath and pulmonary edema.
Not a fit: Patients who refuse to provide informed consent or do not meet the clinical criteria for acute decompensated heart failure will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with heart failure and preserved ejection fraction.
How similar studies have performed: While the approach of creating a comprehensive register for HFpEF patients is not widely tested, similar studies focusing on heart failure management have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients hospitalized with a clinical picture of acute decompensation of heart failure (shortness of breath, orthopnea, clinical signs of "cardiac asthma" and/or "pulmonary edema") in the city clinical hospital named after. V.V. Veresaeva, Moscow. Patients with a confirmed diagnosis in accordance with instrumental (EchoCG) and/or laboratory criteria. Exclusion Criteria: Refusal to sign informed consent to participate in a clinical trial and to process personal data.
Where this trial is running
Moscow and 1 other locations
- Moscow State Clinical Hospital named after V.V. Veresaev — Moscow, Russian Federation (Recruiting)
- National Medical Research Center for Therapy and Preventive Medicine — Moscow, Russian Federation (Recruiting)
Study contacts
- Principal investigator: Yury Timfeev, PhD — National Medical Research Center for Therapy and Preventive Medicine
- Study coordinator: Yury Timofeev, phD
- Email: Timofeev_lab@mail.ru
- Phone: 89150104788
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.